Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marek Z. Kubin"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas S. Griffith, Charles T. Rauch, Pam J. Smolak, Jennifer Y. Waugh, Norman Boiani, David H. Lynch, Craig A. Smith, Raymond G. Goodwin, Marek Z. Kubin
Publikováno v:
The Journal of Immunology. 162:2597-2605
mAbs were generated against the extracellular domain of the four known TNF-related apoptosis-inducing ligand (TRAIL) receptors and tested on a panel of human melanoma cell lines. The specificity of the mAb permitted a precise evaluation of the TRAIL
Publikováno v:
The Journal of Immunology. 161:2833-2840
The observation that TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF cytokine family, induces apoptosis in a number of different tumor cell types led us to compare the tumoricidal effects of TRAIL to those of other TNF family molec
Autor:
Kwan, Joanne
Publikováno v:
Berkeley Technology Law Journal. 2010 Annual Review, Vol. 25 Issue 1, p9-32. 24p.
Autor:
Downing, Jessica jdowning024@gmail.com
Publikováno v:
Journal of Commercial Biotechnology. Sep2012, Vol. 18 Issue 4, p27-33. 7p.
Autor:
Meyer-Leon, Leslie1 LMeyer-Leon@bromsun.com
Publikováno v:
Nature Reviews Drug Discovery. Jul2009, Vol. 8 Issue 7, p530-531. 2p. 2 Color Photographs.
Autor:
Kubin, Marek Z., Parshley, Dorothy L., Din, Wenie, Waugh, Jennifer Y., Davis-Smith, Terri, Smith, Craig A., Macduff, Brian M., Armitage, Richard J., Chin, Wilson, Cassiano, Linda, Borges, Luis, Petersen, Melissa, Trinchieri, Giorgio, Goodwin, Raymond G.
Publikováno v:
European Journal of Immunology; Nov1999, Vol. 29 Issue 11, p3466-3477, 12p
Autor:
Joly, Yann
Publikováno v:
Nature Biotechnology; May2010, Vol. 28 Issue 5, p417-419, 3p, 2 Charts
Autor:
Louwaars, Niels
Publikováno v:
Seed Science Research; Mar2012 Supplement Supplement, Vol. 22 Issue S1, pS9-S14, 1p
Autor:
Alison McLennan
This book explores the interplay between regulation and emerging technologies in the context of synthetic biology, a developing field that promises great benefits, and has already yielded fuels and medicines made with designer micro-organisms. For al